Silverman v. United States, 365 U.S. 505 (1961), was a United States Supreme
Court case in which the Court unanimously held that a federal officer may not, ...
Sep 18, 2014 ... The total infection rate ratio for TNF versus non-TNF group subjects ...
retrospective cohort studies by Beukelman et al. demonstrated that JIA ..... Lovell
DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, et al. ... Listing
J, Strangfeld A, Kary S, Rau R, von Hinueber U, Stoyanova-Scholz M, et al.
scholar.google.com/scholar_lookup?title=Coral reefs may start dissolving when atmospheric CO2 doubles&author=Silverman&publication_year=2009
Dec 1, 2010 ... v. Table of Contents .... and MgrA, are regulators of virulence (Ingavale, van
Wamel et al. .... or depleting innate-like B cells (Goodyear and Silverman 2004; ...
and caspase-independent apoptosis (Haslinger, Strangfeld et al.
Aug 15, 2003 ... Katrin Strangfeld, ... which cleave various cellular substrates, thereby inducing
the demise of the cell (Los et al., 1999). .... although the protective effect was less
pronounced at high concentrations (1% v/v) of the bacterial supernatants. .....
lymphocytes (Weber et al., 2000; Goodyear and Silverman, 2003).
Apr 15, 2011 ... (B+C) To measure Annexin V binding pelleted osteoblasts were ..... O'Seaghdha
M, van Schooten CJ, Kerrigan SW, Emsley J, Silverman GJ, et al. .... Haslinger-
Loffler B, Kahl BC, Grundmeier M, Strangfeld K, Wagner B, et al.
Original Article from The New England Journal of Medicine — Tuberculosis
Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent.
May 21, 2012 ... RF-positivity (75.6% vs 66.7%, p=0.03 in univariate analysis) and anti-CCP
positivity (75.9% vs 62.2, p=0.001) were more frequent .... Strangfeld A,; Hierse F,
; Rau R,; et al .... Silverman GJ,; Schwartzman S,; Townsend M,; et al.
Aug 3, 2011 ... Heijstek MW, Ott de Bruin LM, Bijl M, et al. Ann Rheum Dis .... vaccination versus
rheumatic diseases after the first search ( figure 1 ). ...... Silverman E, Mouy R,
Spiegel L, et al. .... Strangfeld A, Listing J, Herzer P, et al. Risk of ...
Jul 1, 2015 ... Silverman featuring research articles on clinical subjects from scientists working
is a monthly ... moderate/high disease activity at baseline exposed to ≥ 2 versus
1 prior anti-TNF was 0.40 (95% CI ... Harrold, et al: Real-world effectiveness of
RTX ...... Zink A, Strangfeld A, Schneider M, Herzer P, Hierse F,.